BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18565172)

  • 1. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience.
    Gao X; Ren S; Xu C; Sun Y
    BJU Int; 2008 Nov; 102(9):1115-8. PubMed ID: 18565172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A technique for resection of small bladder tumors using a flexible cystoscope on an outpatient basis: bladder tumor resection with newly designed hot cup forceps.
    Muraishi O; Mitsu S; Suzuki K; Koshimizu T; Tokue A
    J Urol; 2001 Nov; 166(5):1817-9. PubMed ID: 11586231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia.
    Jønler M; Lund L; Bisballe S
    BJU Int; 2004 Aug; 94(3):322-5. PubMed ID: 15291860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
    Urologiia; 2004; (6):37-40. PubMed ID: 15719729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
    Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
    Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watchful waiting policy in recurrent Ta G1 bladder tumors.
    Gofrit ON; Pode D; Lazar A; Katz R; Shapiro A
    Eur Urol; 2006 Feb; 49(2):303-6; discussion 306-7. PubMed ID: 16413659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of bladder tumour treatment and follow-up.
    Hedelin H; Holmäng S; Wiman L
    Scand J Urol Nephrol; 2002; 36(5):344-7. PubMed ID: 12487738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection.
    Muraro GB; Grifoni R; Spazzafumo L
    Surg Technol Int; 2005; 14():222-6. PubMed ID: 16525976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C.
    Soler-Martínez J; Vozmediano-Chicharro R; Morales-Jiménez P; Hernández-Alcaraz D; Vivas-Vargas E; Santos García-Vaquero I; Baena-González V
    J Urol; 2007 Dec; 178(6):2337-9. PubMed ID: 17936805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
    Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
    Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transurethral laser treatment in bladder neoplasms].
    Rothauge CF
    Helv Chir Acta; 1978 Jul; 45(3):233-6. PubMed ID: 568124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of fluorescence immunocytochemistry (uCyt+TM) in the postoperative surveillance of bladder cancer].
    Piaton E; Ruffion A; Collet F; Lopez JG; Champetier D; Hoch M; Perrin P; Devonec M
    Prog Urol; 2004 Jun; 14(3):315-9; discussion 319. PubMed ID: 15373172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T1 bladder tumors: value of a second endoscopic resection].
    Rigaud J; Karam G; Braud G; Glemain P; Buzelin JM; Bouchot O
    Prog Urol; 2002 Feb; 12(1):27-30. PubMed ID: 11980011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The neodymium:YAG laser in infiltrating bladder tumors].
    Spitzenpfeil E; Hofstetter A; Reis M; Muschter R
    Fortschr Med; 1989 Sep; 107(26):548-51. PubMed ID: 2807117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolonging of the follow-up intervals for non-invasive bladder tumors].
    Olsen LH; Genster H
    Ugeskr Laeger; 1998 Feb; 160(7):1019-21. PubMed ID: 9477752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of recurrent surface cancer of the urinary bladder (early repeated cystoscopy and biopsy)].
    Lopatkin NA; Martov AG; Gushchin BL; Gnatiuk AP; Ergakov DV; Serebrianyĭ SA
    Urologiia; 2003; (5):45-9. PubMed ID: 14658273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
    Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW
    BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
    Witjes JA; Moonen PM; van der Heijden AG
    Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.